Thursday, April 16, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025
  • Surveys

    Surveys

    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026
    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    Your Body, Your Health Care: A Conversation with Dr. Jeffrey Singer

    July 1, 2025
  • Surveys

    Surveys

    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026
    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    Public Sentiment on the Future of Peptides and Hormone Therapies in U.S. Medicine

    March 17, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Contrarian

Fentanyl Candy Colored Rainbows

We seek enemies, but the only enemy is within

Daily Remedy by Daily Remedy
October 10, 2022
in Contrarian
0
Fentanyl Candy Colored Rainbows

We need enemies. It’s human nature. So we create fights even when there is nothing to fight against. Pretty soon, everything becomes a binary distinction of us versus them. Sometimes it’s useful to think this way. The problems come when we apply this thinking to things that are clearly not binary.

This would be most things in healthcare, particularly those that rise to the level of national health policy, namely this incessant war on drugs we love to fight over. Our latest opponent is fentanyl, a drug that has been around since the 90s but only recently caught the media’s attention when it began appearing in batches of heroin.

Trending the term on Google reveals an interesting pattern. When policy announcements or a policy report hits mainstream media, more people search the term. It’s literally cause and effect. We saw a spike when the DEA declared fentanyl a national health crisis. We see another spike in recent days, when the DEA announced fentanyl is now packaged in different colors and flavors, almost like candy.

Most prominently, we see Google searches asking how much fentanyl can kill you or how much fentanyl is lethal, as though the lethal dose of fentanyl is some magic elixir that can turn life into death. But this is how we look at the war on drugs, as a matter of life and death, a binary construct in which we create enemies out of nothing.

In this never ending war on drugs, we fought immigrants, then physicians, and then the pharmaceutical companies. Now we are back to our original nemesis, the neighborhood drug dealer. That nefarious actor whose sole purpose is to tear the moral fabric of our neighborhoods apart, who uses fentanyl in the most horrid way possible: by disguising it as candy our kids will consume unwittingly.

It’s creating an enemy where none exists. Fostering fear where it’s not needed. Find someone to blame and make that target the enemy. When we have an enemy, we unite in defeating it. And once we unite, we win the war on drugs.

Sometimes it feels it would be worse to have no one to fight against than to lose the war on drugs. For when we have no one to blame, we have no one to fight with.

Creating this binary construct by metamorphosing the war on drugs into a battle of good versus evil, more than anything else, epitomizes the war on drugs. So of course it’s failing; how can it be anything but a failure when we cannot even understand the basic premise of drug abuse?

Drug dealers sell drugs to make money. Children have no money. So why would drug dealers waste drugs they could sell to lace candy for children that have no purchasing power?

Luckily, a few astute epidemiologists are catching on. “It’s exactly the kind of behavior from news organizations that leads to misinformation and panic and detracts from the very real public health dangers that we can and should be focused on.” Dr. Nabarun Dasgupta is quoted as saying. It’s something he would know. As the leader of the UNC Street Drug Analysis Lab, he has made a habit out of fact checking sensationalized announcements coming out of federal agencies like the DEA and CDC.

Including the one that appeared a few days ago, when the CDC reported they are seeing an alarming rise of p-fluorofentanyl, a newly discovered, more potent variant of fentanyl. Normally, raising awareness of a potent variant would be a good thing, if not for the lack of context and the abundance of yellow journalism surrounding the announcement. News outlets portrayed p-fluorofentanyl as the next killer of kids, as the secret weapon of choice for fentanyl-lacing, candy-toting neighborhood drug dealers.

However, upon closer examination, Dr. Dasgupta and his team discovered the variant appeared in combination with cocaine or methamphetamines. Which means it’s likely a contaminant, otherwise known as a lab artifact, found when studying the drugs. Not some recently unveiled variant more deadly than the ones spinning out of the latest COVID omicron mutations.

Dr. Dasgupta and his team concluded the newly discovered drug is not a new wave of fentanyl variants, but an inevitable product of making fentanyl in new ways, which may or may not be significant long term: “It’s the result of different raw materials being used to make fentanyl. We don’t know yet if it causes any specific problems.”

This is a more rational explanation for why a new variant of fentanyl appeared; and a far cry from the sensationalism that garners headlining news. But we love stories of evil actors – the mischievous immigrant, the greedy doctor, and the scheming drug dealer. In reality, much of what we see is the consequence of a poorly regulated industry with no safety standards. It’s the inevitable outcome of poorly conceived, prohibitionary policies against drug use.

But we need enemies. So we continue to create them. The funny thing about it is that the public doesn’t seem to go along with it anymore.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Comments 0

  1. Brian Lynch says:
    4 years ago

    Astute and insightful.

    Reply
  2. Brian Lynch says:
    3 years ago

    https://www.medpagetoday.com/opinion/second-opinions/101577

    More recently, a new fentanyl myth has arisen regarding the idea of “rainbow fentanyl,” which the U.S. DEA described as “brightly-colored fentanyl” being made to “target young Americans.” The DEA did not provide any evidence to support this, and has declined to substantiate their own claim even to major media sources. It is worth noting that before the DEA director made this announcement, “rainbow fentanyl” was not even a searchable term. However, less than 90 days after this announcement there were nearly 1,400 news articles about “rainbow fentanyl” and a proposal from Congress to give the DEA almost $300 million dollars “to fight rainbow fentanyl,” something that nobody in the world of substance use and addiction had ever heard of. This is also not the only time in recent memory that the DEA has denied objective scientific facts to mischaracterize illicit fentanyl products to expand their authority.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

Most employers are unknowingly steering their health plans toward higher costs and reduced control — until they understand how fiduciary missteps and anti-competitive contracts bleed their budgets dry. Katie Talento, a recognized health policy leader, reveals how shifting the network paradigm can save millions by emphasizing independent providers, direct contracting, and innovative tiering models.

Grounded in real-world case studies like Harris Rosen’s community-driven initiative, this episode dives deep into practical strategies to realign incentives—focusing on primary care, specialty care, and transparent vendor relationships. You'll discover how traditional carrier networks are often Trojan horses, locking employers into costly, opaque arrangements that undermine fiduciary duties. Katie breaks down simple yet powerful reforms: owning your data, eliminating conflicts of interest, and outlawing anti-competitive contract clauses.

We explore how a post-network framework—where patients are free to choose providers without restrictive network barriers—can massively reduce costs and improve health outcomes. You'll learn why independent, locally owned providers are vital to rebuilding trust, reducing unnecessary procedures, and reinvesting savings into the community. This conversation offers clarity on the unseen legal landmines employers face and actionable ways to craft health plans built on transparency, independence, and aligned incentives.

Perfect for HR pros, benefits advisors, physicians, and employer leaders committed to transforming healthcare from the ground up. If you’re tired of broken healthcare models draining your budget and frustrating your staff, this episode will empower you to take control by understanding and reshaping the very foundations of employer-sponsored health. Discover the blueprint for smarter, fairer, and more sustainable benefits.

Visit katytalento.com or allbetter.health to connect directly and explore how these innovations can work for your organization. Your path toward a healthier, more cost-effective future starts here.

Chapters

00:00 Introduction to Employer-Sponsored Health Plans
02:50 Understanding ERISA and Fiduciary Responsibilities
06:08 The Misalignment of Clinical and Financial Interests
08:54 Enforcement and Legal Implications for Employers
11:49 Redefining Networks: The Post-Network Framework
25:34 Navigating Healthcare Contracts and Cash Payments
27:31 Understanding Employer Health Plan Structures
28:04 The Role of Benefits Advisors in Health Plans
30:45 Governance and Data Ownership in Health Plans
37:05 Case Study: The Rosen Hotels' Health Model
41:33 Incentivizing Healthy Choices in Healthcare
47:22 Empowering Primary Care and Independent Providers
The Hidden Costs Employers Don’t See in Traditional Health Plans
YouTube Video xhks7YbmBoY
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

by Daily Remedy
March 30, 2026
0

Semaglutide has moved beyond its original indication and now sits at the center of a widening set of clinical questions: cardiovascular risk, kidney disease progression, and even neurodegeneration. The question is no longer whether the drug lowers glucose or reduces weight—it does—but how far those effects extend across systems, and whether evidence from one population can be translated into another without distortion. Large, well-powered trials have produced consistent signals, yet those signals are now being applied in contexts that were...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • Lonely During the Holidays? You're Not Alone.

    Lonely During the Holidays? You’re Not Alone.

    3 shares
    Share 0 Tweet 0
  • Careful When Reporting on Psychedelics Research or Legislation

    1 shares
    Share 0 Tweet 0
  • The Economics of Pollen

    0 shares
    Share 0 Tweet 0
  • Self-care is Healthcare

    0 shares
    Share 0 Tweet 0
  • Factors That Determine Reader Confidence in Healthcare Articles

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy